Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiorenal Syndrome: early-phase trial registry
1 of 3 indexed Cardiorenal Syndrome trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Cardiorenal Syndrome: 3 US clinical trials tracked, 1 recruiting.
Cardiorenal Syndrome is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Procyrion, running 1 of these trials.
Enrollment posture brief
Registry condition cardiorenal-syndrome
OPEN 1 | RECR 33% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Cardiorenal Syndrome lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiorenal Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiorenal Syndrome is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion
NCT05677100
Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study
Yale University
NCT06111768
A Trial of Doxycycline in Renal Disease
University of California, San Francisco
NCT02753426
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiorenal Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiorenal Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiorenal Syndrome page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Cardiorenal Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Procyrion sponsors the most Cardiorenal Syndrome trials on record, review their full trial history before evaluating a specific study. See Procyrion's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiorenal Syndrome condition card totals 3 registered trials; most-linked intervention Placebo (for Doxycycline); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.